Validation of a novel capillairy bloodsampling kit (Demecal) for the detection of HIV antibodies

Completed

• Conditions: 10047438; nvt

• Registration Number: NL-OMON31729
• Lead Sponsor: Demecal Europe BV (www.demecal.eu)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Routine blood sampling requested for HIV positive patient.

Exclusion Criteria

Younger than 18 years of age
No venal blood drawing possible

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Measered HIV-antibody detection levels in capillairy plasma will be compared<br /><br>with venous blood. Tests in both blood samples should be 100% comparable. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>